Synergistic Brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy

被引:4
|
作者
Zhou, Yaofeng [1 ]
Li, Qianying [1 ]
Wu, Yuhao [1 ]
Zhang, Wan [2 ]
Ding, Lu [3 ]
Ji, Chenlin [4 ]
Li, Ping [1 ]
Chen, Tingtao [5 ]
Feng, Lili [6 ]
Tang, Ben Zhong [7 ]
Huang, Xiaolin [1 ]
机构
[1] Nanchang Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Resources, Nanchang 330047, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 1, Dept Thorac Surg, Nanchang 330006, Peoples R China
[3] Nanchang Univ, Affiliated Hosp 1, Jiangxi Hypertens Res Inst, Dept Cardiol, Nanchang 330006, Peoples R China
[4] Westlake Univ, Sch Engn, Hangzhou 310030, Peoples R China
[5] Nanchang Univ, Natl Engn Res Ctr Bioengn Drugs & Technol, Inst Translat Med, Nanchang 330036, Peoples R China
[6] Harbin Engn Univ, Coll Mat Sci & Chem Engn, Key Lab Superlight Mat & Surface Technol, Minist Educ, Harbin 150001, Peoples R China
[7] Chinese Univ Hong Kong Shenzhen CUHK Shenzhen, Sch Sci & Engn, Shenzhen 518172, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
engineered bacteria; multimodal cancer therapy; nanobiohybrid; nanomedicine; synergistic enhancement; PHOTOTHERMAL THERAPY; SYSTEMIC DELIVERY; RNA-INTERFERENCE; IMMUNE-RESPONSES; COATED BACTERIA; TUMOR; NANOPARTICLES; STRATEGY; SURFACE; CHEMOTHERAPY;
D O I
10.1002/adma.202313953
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Engineered bacteria are widely used in cancer treatment because live facultative/obligate anaerobes can selectively proliferate at tumor sites and reach hypoxic regions, thereby causing nutritional competition, enhancing immune responses, and producing anticancer microbial agents in situ to suppress tumor growth. Despite the unique advantages of bacteria-based cancer biotherapy, the insufficient treatment efficiency limits its application in the complete ablation of malignant tumors. The combination of nanomedicine and engineered bacteria has attracted increasing attention owing to their striking synergistic effects in cancer treatment. Engineered bacteria that function as natural vehicles can effectively deliver nanomedicines to tumor sites. Moreover, bacteria provide an opportunity to enhance nanomedicines by modulating the TME and producing substrates to support nanomedicine-mediated anticancer reactions. Nanomedicine exhibits excellent optical, magnetic, acoustic, and catalytic properties, and plays an important role in promoting bacteria-mediated biotherapies. The synergistic anticancer effects of engineered bacteria and nanomedicines in cancer therapy are comprehensively summarized in this review. Attention is paid not only to the fabrication of nanobiohybrid composites, but also to the interpromotion mechanism between engineered bacteria and nanomedicine in cancer therapy. Additionally, recent advances in engineered bacteria-synergized multimodal cancer therapies are highlighted. Herein, the first systematic and comprehensive review of the development of engineered bacteria in cancer, is provided; and the unique advantages of combining bacteria as anticancer agents with nanomedicines are discussed. This review focuses on the role of bacteria in cancer therapy, integration strategy of bacteria and nanotherapeutic drugs, synergistic mechanism of bacteria and nanomedicines, and bacteria-synergized multimodal cancer therapy. image
引用
收藏
页数:42
相关论文
共 50 条
  • [1] Engineered anti-cancer nanomedicine for synergistic ferroptosis-immunotherapy
    Zhang, Xinyu
    Ge, Haiyan
    Ma, Yanling
    Song, Linlin
    Ma, Yansong
    Tian, Guanglong
    Wang, Lei
    Meng, Qingwei
    Sun, Xiao
    CHEMICAL ENGINEERING JOURNAL, 2023, 455 (455)
  • [2] Synthetic engineered bacteria for cancer therapy
    Gong, Tong
    Wu, Jinhui
    EXPERT OPINION ON DRUG DELIVERY, 2023, 20 (07) : 993 - 1013
  • [3] Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectives
    Zhang, Rui Xue
    Wong, Ho Lun
    Xue, Hui Yi
    Eoh, June Young
    Wu, Xiao Yu
    JOURNAL OF CONTROLLED RELEASE, 2016, 240 : 489 - 503
  • [4] Programming the lifestyles of engineered bacteria for cancer therapy
    Shengwei Fu
    Rongrong Zhang
    Yanmei Gao
    Jiarui Xiong
    Ye Li
    Lu Pu
    Aiguo Xia
    Fan Jin
    National Science Review, 2023, 10 (05) : 138 - 153
  • [5] Programming the lifestyles of engineered bacteria for cancer therapy
    Fu, Shengwei
    Zhang, Rongrong
    Gao, Yanmei
    Xiong, Jiarui
    Li, Ye
    Pu, Lu
    Xia, Aiguo
    Jin, Fan
    NATIONAL SCIENCE REVIEW, 2023, 10 (05)
  • [6] A nanomedicine enables synergistic chemo/photodynamic therapy for pancreatic cancer treatment
    Zhu, Liwei
    Lin, Shanmeng
    Cui, Wenqiang
    Xu, Youwei
    Wang, Liang
    Wang, Zhaohan
    Yuan, Shuguang
    Zhang, Yichuan
    Fan, Yingfang
    Geng, Jin
    BIOMATERIALS SCIENCE, 2022, 10 (13) : 3624 - 3636
  • [7] Nanomedicine-mediated ferroptosis targeting strategies for synergistic cancer therapy
    Yin, Weimin
    Chang, Jiao
    Sun, Jiuyuan
    Zhang, Tingting
    Zhao, Yuge
    Li, Yongyong
    Dong, Haiqing
    JOURNAL OF MATERIALS CHEMISTRY B, 2023, 11 (06) : 1171 - 1190
  • [8] Fenton reaction-based nanomedicine in cancer chemodynamic and synergistic therapy
    Meng, Xiangyu
    Zhang, Xuezhong
    Liu, Mei
    Cai, Bo
    He, Nongyue
    Wang, Zhifei
    APPLIED MATERIALS TODAY, 2020, 21
  • [9] Carrier free nanomedicine for synergistic cancer therapy by initiating apoptosis and paraptosis
    Zheng, Rongrong
    Liu, Yibin
    Yu, Baixue
    Zhao, Linping
    Yang, Ni
    Chen, Ali
    Xu, Lin
    Cheng, Hong
    Jiang, Xueyan
    Li, Shiying
    JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2022, 622 : 298 - 308
  • [10] Sequential catalytic nanomedicine augments synergistic chemodrug and chemodynamic cancer therapy
    Liang, Ruijie
    Chen, Yu
    Huo, Minfeng
    Zhang, Jun
    Li, Yongsheng
    NANOSCALE HORIZONS, 2019, 4 (04) : 890 - 901